Limitations
ascites, primary tumors
ASCITES, PRIMARY TUMORS
As a single-center registry study, we cannot prove a causal effect of PIPAC (especially on survival). Our patient cohort was heterogeneous with regard to their primary tumors and prior treatment regimes. We measured ascites volumes intraoperatively only, not accounting for additional ascites punctures. These measurements, therefore, yield only a rough estimate of a patient’s actual ascites burden.